CF PharmTech Updates Board Composition and Committee Leadership

Bulletin Express06-26

Hong Kong, 26 June 2026—CF PharmTech, Inc. announced an updated roster of 11 board members and detailed the latest committee assignments.

The board comprises: • 5 Executive Directors – chaired by Dr. Liang Bill Wenqing • 2 Non-executive Directors • 4 Independent Non-executive Directors

Independent directors now represent 36.36% of the board, meeting typical Hong Kong listing governance norms.

Committee structure 1. Audit Committee • Chair: Ms. Wang Lijuan (Independent) • Members: Dr. Jin Jian, Mr. IP Wang Hoi

2. Remuneration and Appraisal Committee • Chair: Mr. Wei Shirong (Independent) • Members: Dr. Jin Jian, Dr. Liang Bill Wenqing

3. Nomination Committee • Chair: Mr. IP Wang Hoi (Independent) • Members: Ms. Zhu Yuyu, Dr. Liang Bill Wenqing

Leadership Highlights • Dr. Liang Bill Wenqing continues as Board Chair and serves on both the Audit and Nomination Committees, underscoring active executive involvement in governance. • Independent directors chair all three key committees, concentrating oversight responsibilities among non-management members.

The announcement reinforces CF PharmTech’s commitment to maintaining a balanced governance framework aligned with market best practices.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170299682?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170299682","market":"us","top_or_hot":-1,"title":"CF PharmTech Updates Board Composition and Committee Leadership","media":"Bulletin Express","content":"<p>Hong Kong, 26 June 2026—CF PharmTech, Inc. announced an updated roster of 11 board members and detailed the latest committee assignments.</p>\n<p>The board comprises:\n• 5 Executive Directors – chaired by Dr. Liang Bill Wenqing  \n• 2 Non-executive Directors  \n• 4 Independent Non-executive Directors</p>\n<p>Independent directors now represent 36.36% of the board, meeting typical Hong Kong listing governance norms.</p>\n<p>Committee structure  \n1. Audit Committee  \n   • Chair: Ms. Wang Lijuan (Independent)  \n   • Members: Dr. Jin Jian, Mr. IP Wang Hoi</p>\n<p>2. Remuneration and Appraisal Committee  \n   • Chair: Mr. Wei Shirong (Independent)  \n   • Members: Dr. Jin Jian, Dr. Liang Bill Wenqing</p>\n<p>3. Nomination Committee  \n   • Chair: Mr. IP Wang Hoi (Independent)  \n   • Members: Ms. Zhu Yuyu, Dr. Liang Bill Wenqing</p>\n<p>Leadership Highlights  \n• Dr. Liang Bill Wenqing continues as Board Chair and serves on both the Audit and Nomination Committees, underscoring active executive involvement in governance.  \n• Independent directors chair all three key committees, concentrating oversight responsibilities among non-management members.</p>\n<p>The announcement reinforces CF PharmTech’s commitment to maintaining a balanced governance framework aligned with market best practices.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech Updates Board Composition and Committee Leadership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech Updates Board Composition and Committee Leadership\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong, 26 June 2026—CF PharmTech, Inc. announced an updated roster of 11 board members and detailed the latest committee assignments.</p>\n<p>The board comprises:\n• 5 Executive Directors – chaired by Dr. Liang Bill Wenqing  \n• 2 Non-executive Directors  \n• 4 Independent Non-executive Directors</p>\n<p>Independent directors now represent 36.36% of the board, meeting typical Hong Kong listing governance norms.</p>\n<p>Committee structure  \n1. Audit Committee  \n   • Chair: Ms. Wang Lijuan (Independent)  \n   • Members: Dr. Jin Jian, Mr. IP Wang Hoi</p>\n<p>2. Remuneration and Appraisal Committee  \n   • Chair: Mr. Wei Shirong (Independent)  \n   • Members: Dr. Jin Jian, Dr. Liang Bill Wenqing</p>\n<p>3. Nomination Committee  \n   • Chair: Mr. IP Wang Hoi (Independent)  \n   • Members: Ms. Zhu Yuyu, Dr. Liang Bill Wenqing</p>\n<p>Leadership Highlights  \n• Dr. Liang Bill Wenqing continues as Board Chair and serves on both the Audit and Nomination Committees, underscoring active executive involvement in governance.  \n• Independent directors chair all three key committees, concentrating oversight responsibilities among non-management members.</p>\n<p>The announcement reinforces CF PharmTech’s commitment to maintaining a balanced governance framework aligned with market best practices.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1170299682","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170299682","pubTimestamp":1782482697,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong, 26 June 2026—CF PharmTech, Inc. announced an updated roster of 11 board members and detailed the latest committee assignments. The board comprises: • 5 Executive Directors – chaired by Dr....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech更新董事会组成和委员会领导层","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"Hong Kong, 26 June 2026—CF PharmTech, Inc. announced an updated roster of 11 board members and detailed the latest committee assignments.\nThe board comprises:\n• 5 Executive Directors – chaired by Dr. Liang Bill Wenqing  \n• 2 Non-executive Directors  \n• 4 Independent Non-executive Directors\nIndependent directors now represent 36.36% of the board, meeting typical Hong Kong listing governance norms.\nCommittee structure  \n1. Audit Committee  \n   • Chair: Ms. Wang Lijuan (Independent)  \n   • Members: Dr. Jin Jian, Mr. IP Wang Hoi\n2. Remuneration and Appraisal Committee  \n   • Chair: Mr. Wei Shirong (Independent)  \n   • Members: Dr. Jin Jian, Dr. Liang Bill Wenqing\n3. Nomination Committee  \n   • Chair: Mr. IP Wang Hoi (Independent)  \n   • Members: Ms. Zhu Yuyu, Dr. Liang Bill Wenqing\nLeadership Highlights  \n• Dr. Liang Bill Wenqing continues as Board Chair and serves on both the Audit and Nomination Committees, underscoring active executive involvement in governance.  \n• Independent directors chair all three key committees, concentrating oversight responsibilities among non-management members.\nThe announcement reinforces CF PharmTech’s commitment to maintaining a balanced governance framework aligned with market best practices.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170299682","isCrawlerRequest":true}